Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Innvotek Pharmaceuticals

Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx54product presentations
G37generic molecules
DF4dosage-form groups
TA1therapeutic areas
PKR54current price records
REG50registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage98%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Portfolio intelligence

Therapeutic mix

Unclassified52 products · 96%
Fluoroquinolone antibacterials2 products · 4%
Formulation footprint

Dosage forms

Tablet40 products
Drops8 products
Capsule5 products
Ointment1 products
Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 InvofloxCiprofloxacin 4presentations 250 mg, 3 mg/mL, 500 mg, 750 mg · Tablet, Drops #2 BisorenBisoprolol fumarate 3presentations 10 mg, 2.5 mg, 5 mg · Tablet #3 ChimeClarithromycin 2presentations 250 mg, 500 mg · Tablet #4 DuzestFluoxetine 2presentations 10 mg, 20 mg · Tablet #5 InvolineLinezolid 2presentations 400 mg, 600 mg · Tablet #6 LetaseLetrozole 2presentations 2.5 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median1836% of comparable products
Near market median26within ±5% of median
Above market median612% of comparable products
Lowest-price equivalents4ties included
Company median price position -2.2% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Xalanol -T 50 mcg/mLLatanoprost · Ophthalmic drops · 2.5ml PKR 289.36/mL-54.1% vs market median Incot 400 mgSulfamethoxazole · Tablet · 40x10's PKR 2.31/tablet-33.8% vs market median Misabon 200 mcgMisoprostol · Tablet · 10's PKR 14.30/tablet-30.8% vs market median Misabon 200 mcgMisoprostol · Tablet · 28's PKR 14.30/tablet-30.8% vs market median Bisoren 2.5 mgBisoprolol fumarate · Tablet · 14's PKR 2.95/tablet-30.5% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,362 products · 118 generics 23shared generics Atco Laboratories Limited275 products · 94 generics 22shared generics Epharm Laboratories144 products · 67 generics 22shared generics Valor Pharmaceuticals218 products · 97 generics 21shared generics TABROS PHARMA (PVT). LTD.179 products · 64 generics 21shared generics Genome Pharmaceuticals (Pvt.) Ltd,149 products · 71 generics 21shared generics
Regulatory & price activity

Observed database signals

Registration numbers50
Price-history records58
Products with price history4
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date1 Jul 2025
Latest source observation9 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

54 results
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Acivir Eye ointment Aciclovir 3 % Ointment 4.5gm 082035 PKR 321.23 PKR 71.38/g No comparator
Am-Invo Artemether 20 mg Tablet 16's 079983 PKR 604.35 PKR 37.77/tablet Near median
Arexel DS Artemether + Lumefantrine 40 mg + 240 mg Tablet 10's 094211 PKR 585.53 PKR 58.55/tablet 8% below median
Arexel Forte 80/480 Artemether 80 mg Tablet 6's 094210 PKR 623.31 PKR 103.89/tablet Near median
Bisoren Bisoprolol fumarate 5 mg Tablet 20's 106404 PKR 178.75 PKR 8.94/tablet 23% below median
Bisoren Bisoprolol fumarate 10 mg Tablet 20's 106405 PKR 321.76 PKR 16.09/tablet 27% below median
Bisoren Bisoprolol fumarate 2.5 mg Tablet 14's 106403 PKR 41.31 PKR 2.95/tablet 31% below median
CAI Acetazolamide 250 mg Tablet 30's 089623 PKR 313.18 PKR 10.44/tablet Near median
Cardocap Clopidogrel 75 mg Tablet 10's 040556 PKR 254.96 PKR 25.50/tablet Near median
Chime Clarithromycin 250 mg Tablet 10's 040189 PKR 462.75 PKR 46.28/tablet Near median
Chime Clarithromycin 500 mg Tablet 10's 040190 PKR 840.42 PKR 84.04/tablet Near median
Duzest Fluoxetine 20 mg Tablet 10's 094215 PKR 120.25 PKR 12.03/tablet Near median
Duzest Fluoxetine 10 mg Tablet 10's 094214 PKR 75.55 PKR 7.56/tablet 16% above median
Fluin Fluconazole 150 mg Capsule 1's 072283 PKR 282.37 PKR 282.37/capsule 8% above median
Genek Gentamicin 0.3 % Ophthalmic drops 7.5ml 026953 PKR 43.63 PKR 5.82/mL Near median
Incot Sulfamethoxazole 400 mg Tablet 40x10's 052745 PKR 924.98 PKR 2.31/tablet 34% below median
Incot DS Sulfamethoxazole + Trimethoprim 400 mg + 160 mg Tablet 10x10's 052746 PKR 354.42 PKR 3.54/tablet No comparator
Infolx Iron polymaltose complex + Folic acid 100 mg + 0.35 mg Tablet 30's 098177 PKR 445.76 PKR 14.86/tablet 13% above median
Inmox Moxifloxacin 400 mg Tablet 5's 079984 PKR 904.37 PKR 180.87/tablet Near median
Invofen Clomifene citrate 50 mg Tablet 10's 098178 PKR 399.62 PKR 39.96/tablet Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.